Jonathan S. Sobel - 21 Aug 2026 Form 4 Insider Report for Hilltop Holdings Inc. (HTH)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
25 Aug 2026, 19:31:43 UTC
Prior SEC filing
24 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jonathan S. Sobel

Key filing fact

Jonathan S. Sobel filed Form 4 for Hilltop Holdings Inc. (HTH) on 25 Aug 2026.

Key facts

  • This page summarizes Jonathan S. Sobel's Form 4 filing for Hilltop Holdings Inc. (HTH).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 25 Aug 2026, 19:31.

Change

  • Previous filing in this sequence was filed on 24 Jul 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001086618 Primary reporting owner

SOBEL JONATHAN S

Relationship
Hilltop Securities Chairman, Director
Address
6565 HILLCREST AVE, DALLAS
Signature
/s/ Jonathan S. Sobel
Signature date
25 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HTH transaction

Common Stock

Award

Transaction value
Shares
+122
Change %
+0.09%
Price
$0.000000*
Shares after
129,917
Date
21 Aug 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares acquired pursuant to the reinvestment of dividends.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .